Cargando…
Uterine Artery Embolization with Small-Sized Particles for the Treatment of Symptomatic Adenomyosis: A 42-Month Clinical Follow-Up
PURPOSE: To assess the long-term outcome of performing uterine artery embolization (UAE) using small particles in women with symptomatic adenomyosis (AD). METHODS: Twenty-seven consecutive women (median age 42 years, range 29–53 years) with AD, in eight cases AD combined with fibroids, who underwent...
Autores principales: | Yuan, Kai, Zhang, Jin Long, Yan, Jie Yu, Yuan, Bing, Fu, Jin Xin, Wang, Yan, Sun, Xue Dong, Guan, Yang, Duan, Feng, Wang, Mao Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289687/ https://www.ncbi.nlm.nih.gov/pubmed/34290527 http://dx.doi.org/10.2147/IJGM.S312618 |
Ejemplares similares
-
Uterine Artery Embolization Versus Hysterectomy in the Treatment of Symptomatic Adenomyosis: Protocol for the Randomized QUESTA Trial
por: de Bruijn, Annefleur Machteld, et al.
Publicado: (2018) -
An update on uterine artery embolization for uterine leiomyomata and adenomyosis of the uterus
por: Kröncke, Thomas
Publicado: (2023) -
Uterine Artery Embolization for Symptomatic Adenomyosis: 7-Year Clinical Follow-up Using UFS-Qol Questionnaire
por: de Bruijn, Annefleur M., et al.
Publicado: (2017) -
Long‐term durability of uterine artery embolisation for treatment of symptomatic adenomyosis
por: Ma, Jolande, et al.
Publicado: (2021) -
Our Experience with Hydrogel-Coated Trisacryl Microspheres in Uterine Artery Embolization for the Treatment of Symptomatic Uterine Fibroids and Adenomyosis: A Follow-Up of 11 Years
por: Tsikouras, Panagiotis, et al.
Publicado: (2023)